Company Name or Ticker Symbol
Search for other Categories

Acelrx Pharmaceuticals Inc  (ACRX)
Other Ticker:  
    Sector  Healthcare    Industry Major Pharmaceutical Preparations

ACRX's Revenue Year on Year Growth by Quarter and Year

Acelrx Pharmaceuticals Inc's Revenue results by quarter and year

Select the Comparisons : Select the Ratio:                        
ACRX Revenue (in millions $) FY 2016 FY 2015 FY 2014 FY 2013
IV Quarter December 6.44 1.73 0.23 27.61
III Quarter September 3.37 15.43 4.83 0.55
II Quarter June 4.53 1.92 0.07 0.41
I Quarter March 3.03 0.18 0.10 0.94
FY   17.37 19.26 5.23 29.51

Financial Statements
Acelrx Pharmaceuticals Inc's forth quarter 2016 Revenue $ 6.44 millions ACRX's Income Statement
Acelrx Pharmaceuticals Inc's forth quarter 2015 Revenue $ 1.73 millions Quarterly ACRX's Income Statement
ACRX's Growth by Division See ACRX's Growth by Segment

ACRX Revenue ( Y/Y Growth %) 2016
2015 2014 2013
IV Quarter December 271.97 % 652.17 % -99.17 % 1543.45 %
III Quarter September -78.16 % 219.46 % 778.18 % 223.53 %
II Quarter June 135.94 % 2642.86 % -82.93 % 86.36 %
I Quarter March 1583.33 % 80 % -89.36 % 184.85 %
FY   -9.84 % 268.26 % -82.28 % -

ACRX Revenue Growth Comment
Acelrx Pharmaceuticals Inc reported Revenue surge of 271.97% year on year in the forth quarter, to $ 6.44 millions, this is lower than Acelrx Pharmaceuticals Inc's recent average Revenue surge of 502.55%.

Looking into forth quarter results within Major Pharmaceutical Preparations industry 8 other companies have achieved higher Revenue growth. While Acelrx Pharmaceuticals Inc' s Revenue doubling of 271.97% ranks overall at the positon no. 89 in the forth quarter.

Revenue Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #9
Healthcare Sector #20
S&P 500 #89
Revenue Y/Y Growth Statistics
High Average Low
2609.86 % 502.55 % -99.18 %
(Jun 30 2015)   (Dec 31 2014)

You need to upgrade your Flash Player

Other Revenue Growth
Major Pharmaceutical Preparations Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
ACRX's Revenue Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for ACRX's Competitors
Revenue Growth for Acelrx Pharmaceuticals Inc's Suppliers
Revenue Growth for ACRX's Customers

You may also want to know
ACRX's Annual Growth Rates ACRX's Profitability Ratios ACRX's Asset Turnover Ratio ACRX's Dividend Growth
ACRX's Roe ACRX's Valuation Ratios ACRX's Financial Strength Ratios ACRX's Dividend Payout Ratio
ACRX's Roa ACRX's Inventory Turnover Ratio ACRX's Growth Rates ACRX's Dividend Comparisons

Companies with similar Revenue doubling for the quarter ending Dec 31 2016 within Healthcare SectorY/Y Change %Revenue for the quarter ending Dec 31 2016
Juno Therapeutics, Inc.  409.47 %$ 409.465 millions
Eagle Pharmaceuticals, Inc.  346.31 %$ 346.315 millions
Sarepta Therapeutics, Inc.  332.64 %$ 332.642 millions
Acelrx Pharmaceuticals Inc  271.97 %$ 271.965 millions
Agios Pharmaceuticals Inc  264.23 %$ 264.233 millions
Organovo Holdings, Inc.  250.91 %$ 250.915 millions
Neuralstem, Inc.  249.84 %$ 249.840 millions
Cytokinetics Inc  239.62 %$ 239.623 millions
Viveve Medical, Inc.  226.06 %$ 226.064 millions
Intra-cellular Therapies, Inc.  219.30 %$ 219.303 millions
Ionis Pharmaceuticals Inc  210.93 %$ 210.929 millions
Portola Pharmaceuticals Inc  210.22 %$ 210.217 millions
Sorrento Therapeutics, Inc.  200.60 %$ 200.598 millions
Catasys, Inc.  200.16 %$ 200.158 millions
Invitae Corp  192.19 %$ 192.186 millions
Merrimack Pharmaceuticals Inc  185.93 %$ 185.928 millions
Dariohealth Corp.  172.08 %$ 172.078 millions
Juniper Pharmaceuticals Inc  152.38 %$ 152.382 millions

Advance Monthly Sales
Consumer Price Index CPI
Producer Price Index PPI
Retail Inventories
Personal Income
Gross Domestic Product GDP
Money Supply
Industrial Production
Employment Situation
US International Trade
Factory Orders
Durable Goods
Construction Spending
Housing Starts
Vehicle Unit Sales

Event Calendar
LTBR's Profile
Stock Price
LTBR's Financials
LTBR's Expectations
Business Description
Charts & Quotes
LTBR's News
LTBR's Competitors
Customers & Markets
Economic Indicators
LTBR's Growth
Company Segments

At a Glance
Growth Rates
Financial Strength

At a Glance
Sectors & Industries

Stock Performance
Growth Rates
Financial Strength
Management Effectivness

At a Glance

Financial Terms
Technical Analysis
Fundamental Analysis
Energy Terms
Manufacturing Terms
Transportation Terms
Health Care
Insurance Terms
Economy Terms
Hotel & Leisure Terms

About us
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com